Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 80

1.

Aromatic DNA adducts and breast cancer risk: a case-cohort study within the EPIC-Spain.

Agudo A, Peluso M, Munnia A, Luján-Barroso L, Barricarte A, Amiano P, Navarro C, Sánchez MJ, Quirós JR, Ardanaz E, Larrañaga N, Tormo MJ, Chirlaque MD, Rodríguez-Barranco M, Sánchez-Cantalejo E, Cellai F, Bonet C, Sala N, González CA.

Carcinogenesis. 2017 Jul 1;38(7):691-698. doi: 10.1093/carcin/bgx047.

PMID:
28535209
2.

Aromatic DNA adducts and risk of gastrointestinal cancers: a case-cohort study within the EPIC-Spain.

Agudo A, Peluso M, Munnia A, Luján-Barroso L, Sánchez MJ, Molina-Montes E, Sánchez-Cantalejo E, Navarro C, Tormo MJ, Chirlaque MD, Barricarte A, Ardanaz E, Amiano P, Dorronsoro M, Quirós JR, Piro S, Bonet C, Sala N, González CA.

Cancer Epidemiol Biomarkers Prev. 2012 Apr;21(4):685-92. doi: 10.1158/1055-9965.EPI-11-1205. Epub 2012 Feb 7.

3.

The relationship between genetic damage from polycyclic aromatic hydrocarbons in breast tissue and breast cancer.

Rundle A, Tang D, Hibshoosh H, Estabrook A, Schnabel F, Cao W, Grumet S, Perera FP.

Carcinogenesis. 2000 Jul;21(7):1281-9.

PMID:
10874004
4.

Aromatic adducts and lung cancer risk in the European Prospective Investigation into Cancer and Nutrition (EPIC) Spanish cohort.

Gilberson T, Peluso ME, Munia A, Luján-Barroso L, Sánchez MJ, Navarro C, Amiano P, Barricarte A, Quirós JR, Molina-Montes E, Sánchez-Cantalejo E, Tormo MJ, Chirlaque MD, Ardanaz E, Dorronsoro M, Confortini M, Bonet C, Sala N, González CA, Agudo A.

Carcinogenesis. 2014 Sep;35(9):2047-54. doi: 10.1093/carcin/bgu098. Epub 2014 Apr 29.

PMID:
24845263
5.

Polymorphism in the DNA repair gene XPD, polycyclic aromatic hydrocarbon-DNA adducts, cigarette smoking, and breast cancer risk.

Terry MB, Gammon MD, Zhang FF, Eng SM, Sagiv SK, Paykin AB, Wang Q, Hayes S, Teitelbaum SL, Neugut AI, Santella RM.

Cancer Epidemiol Biomarkers Prev. 2004 Dec;13(12):2053-8.

6.

Polycyclic aromatic hydrocarbons and postmenopausal breast cancer: An evaluation of effect measure modification by body mass index and weight change.

Niehoff N, White AJ, McCullough LE, Steck SE, Beyea J, Mordukhovich I, Shen J, Neugut AI, Conway K, Santella RM, Gammon MD.

Environ Res. 2017 Jan;152:17-25. doi: 10.1016/j.envres.2016.09.022. Epub 2016 Oct 12.

7.

Environmental toxins and breast cancer on Long Island. I. Polycyclic aromatic hydrocarbon DNA adducts.

Gammon MD, Santella RM, Neugut AI, Eng SM, Teitelbaum SL, Paykin A, Levin B, Terry MB, Young TL, Wang LW, Wang Q, Britton JA, Wolff MS, Stellman SD, Hatch M, Kabat GC, Senie R, Garbowski G, Maffeo C, Montalvan P, Berkowitz G, Kemeny M, Citron M, Schnabel F, Schuss A, Hajdu S, Vinceguerra V.

Cancer Epidemiol Biomarkers Prev. 2002 Aug;11(8):677-85.

8.

Polycyclic aromatic hydrocarbon-DNA adducts and survival among women with breast cancer.

Sagiv SK, Gaudet MM, Eng SM, Abrahamson PE, Shantakumar S, Teitelbaum SL, Bell P, Thomas JA, Neugut AI, Santella RM, Gammon MD.

Environ Res. 2009 Apr;109(3):287-91. doi: 10.1016/j.envres.2008.11.005. Epub 2009 Jan 31.

9.

PAH-DNA adducts, cigarette smoking, GST polymorphisms, and breast cancer risk.

McCarty KM, Santella RM, Steck SE, Cleveland RJ, Ahn J, Ambrosone CB, North K, Sagiv SK, Eng SM, Teitelbaum SL, Neugut AI, Gammon MD.

Environ Health Perspect. 2009 Apr;117(4):552-8. doi: 10.1289/ehp.0800119. Epub 2008 Dec 10.

10.

Polymorphisms in XRCC1 modify the association between polycyclic aromatic hydrocarbon-DNA adducts, cigarette smoking, dietary antioxidants, and breast cancer risk.

Shen J, Gammon MD, Terry MB, Wang L, Wang Q, Zhang F, Teitelbaum SL, Eng SM, Sagiv SK, Gaudet MM, Neugut AI, Santella RM.

Cancer Epidemiol Biomarkers Prev. 2005 Feb;14(2):336-42.

11.

Dependence of cancer risk from environmental exposures on underlying genetic susceptibility: an illustration with polycyclic aromatic hydrocarbons and breast cancer.

Shen J, Liao Y, Hopper JL, Goldberg M, Santella RM, Terry MB.

Br J Cancer. 2017 Apr 25;116(9):1229-1233. doi: 10.1038/bjc.2017.81. Epub 2017 Mar 28.

12.

Xeroderma pigmentosum complementation group C genotypes/diplotypes play no independent or interaction role with polycyclic aromatic hydrocarbons-DNA adducts for breast cancer risk.

Shen J, Gammon MD, Terry MB, Teitelbaum SL, Eng SM, Neugut AI, Santella RM.

Eur J Cancer. 2008 Mar;44(5):710-7. Epub 2007 Nov 28.

13.

Polycyclic aromatic hydrocarbon-DNA adducts and breast cancer: a pooled analysis.

Gammon MD, Sagiv SK, Eng SM, Shantakumar S, Gaudet MM, Teitelbaum SL, Britton JA, Terry MB, Wang LW, Wang Q, Stellman SD, Beyea J, Hatch M, Kabat GC, Wolff MS, Levin B, Neugut AI, Santella RM.

Arch Environ Health. 2004 Dec;59(12):640-9.

14.

Polymorphisms in nucleotide excision repair genes, polycyclic aromatic hydrocarbon-DNA adducts, and breast cancer risk.

Crew KD, Gammon MD, Terry MB, Zhang FF, Zablotska LB, Agrawal M, Shen J, Long CM, Eng SM, Sagiv SK, Teitelbaum SL, Neugut AI, Santella RM.

Cancer Epidemiol Biomarkers Prev. 2007 Oct;16(10):2033-41.

15.

Polycyclic aromatic hydrocarbon (PAH)-DNA adducts and breast cancer: modification by gene promoter methylation in a population-based study.

White AJ, Chen J, McCullough LE, Xu X, Cho YH, Teitelbaum SL, Neugut AI, Terry MB, Hibshoosh H, Santella RM, Gammon MD.

Cancer Causes Control. 2015 Dec;26(12):1791-802. doi: 10.1007/s10552-015-0672-7. Epub 2015 Sep 25.

16.

Aromatic DNA adducts and polymorphisms in metabolic genes in healthy adults: findings from the EPIC-Spain cohort.

Agudo A, Peluso M, Sala N, Capellá G, Munnia A, Piro S, Marín F, Ibáñez R, Amiano P, Tormo MJ, Ardanaz E, Barricarte A, Chirlaque MD, Dorronsoro M, Larrañaga N, Martínez C, Navarro C, Quirós JR, Sánchez MJ, González CA.

Carcinogenesis. 2009 Jun;30(6):968-76. doi: 10.1093/carcin/bgp062. Epub 2009 Mar 23.

PMID:
19307236
17.

Bulky DNA adduct formation and risk of bladder cancer.

Castaño-Vinyals G, Talaska G, Rothman N, Alguacil J, Garcia-Closas M, Dosemeci M, Cantor KP, Malats N, Real FX, Silverman D, Serra C, Carrato A, Tardon A, Garcia-Closas R, Kogevinas M, Vermeulen R.

Cancer Epidemiol Biomarkers Prev. 2007 Oct;16(10):2155-9.

18.

IGHMBP2 Thr671Ala polymorphism might be a modifier for the effects of cigarette smoking and PAH-DNA adducts to breast cancer risk.

Shen J, Terry MB, Gammon MD, Gaudet MM, Teitelbaum SL, Eng SM, Sagiv SK, Neugut AI, Santella RM.

Breast Cancer Res Treat. 2006 Sep;99(1):1-7. Epub 2006 Jun 5.

PMID:
16752224
19.

Carcinogen-DNA adducts in human breast tissue.

Perera FP, Estabrook A, Hewer A, Channing K, Rundle A, Mooney LA, Whyatt R, Phillips DH.

Cancer Epidemiol Biomarkers Prev. 1995 Apr-May;4(3):233-8.

20.

Bulky DNA adducts and breast cancer risk in the prospective EPIC-Italy study.

Saieva C, Peluso M, Masala G, Munnia A, Ceroti M, Piro S, Sera F, Bendinelli B, Pala V, Sieri S, Tumino R, Giurdanella MC, Panico S, Mattiello A, Vineis P, Polidoro S, Matullo G, Palli D.

Breast Cancer Res Treat. 2011 Sep;129(2):477-84. doi: 10.1007/s10549-011-1472-8. Epub 2011 Mar 31.

PMID:
21452020

Supplemental Content

Support Center